✅ About

Danazol capsules are a prescription medication used to treat certain hormone-related conditions, such as endometriosis and fibrocystic breast disease. Danazol belongs to a class of drugs called synthetic androgens, which are man-made forms of male hormones. It helps reduce pain and control symptoms by influencing hormone levels in the body. Danazol is not a first-line treatment and is generally prescribed when other therapies have not been effective or are not suitable.

✅ Mechanisms of Action

Danazol works by altering the balance of hormones in the body. It suppresses the production of certain female hormones like estrogen and progesterone by inhibiting the release of gonadotropins from the pituitary gland. This leads to decreased stimulation of the ovaries and reduces the symptoms associated with hormone-dependent conditions. Danazol also has weak androgenic effects, which further influence hormone regulation.

Danazol should not be used by individuals with liver disease, breast cancer, pregnancy, or unexplained vaginal bleeding. Before starting treatment, it’s important to discuss your full medical history with your healthcare provider, especially if you have high blood pressure, diabetes, or a tendency for fluid retention. Regular monitoring may be required during treatment to ensure the drug’s effects are safe for you.

✅ Interactions

Danazol can interact with several other medications, including anticoagulants (blood thinners), insulin or other diabetes medications, and hormonal therapies. It may also affect liver enzymes, which can change how other drugs are processed in your body. Be sure to inform your doctor about all the medications, supplements, or herbal products you are taking before starting danazol.

✅ Adverse Reactions / Side Effects
Common side effects include weight gain, acne, muscle cramps, headache, and mood changes. Some patients may also experience hot flashes, changes in menstrual cycles, or an increase in hair growth. Rare but serious side effects include liver problems, high blood pressure, and blood clots. If you notice severe symptoms such as chest pain, difficulty breathing, or significant mood swings, contact your doctor immediately.

The drug is also not advised during breastfeeding because it may pass into breast milk and affect the nursing baby. Always consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before starting this medication.

Store this medication at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.

1. Danazol package insert. Columbus, Ohio: American Health Packaging; 2010 Nov.
2. Danocrine (danazol) package insert. Bridgewater, New Jersey: sanofi-aventis U.S. LLC; 2011 Dec.
3. Konishi H, Takenaka A, Minouchi T, et al. Impairment of CYP3A4 capacity in patients receiving danazol therapy: examination on oxidative cortisol metabolism. Horm Metab Res 2001;33:628—30.
4. Meeks ML, Mahaffey KW, Katz MD. Danazol increases the anticoagulant effect of warfarin. Ann Pharmacother 1992;26:641—2.
5. Zocor (simvastatin) package insert. Whitehouse Station, NJ: Merck & Co., Inc.; 2015 Feb.
6. Mevacor® (lovastatin) package insert. Whitehouse Station, NJ: Merck & Co., Inc.; 2005 Nov.
7. Andreou ER, Ledger S. Potential drug interaction between simvastatin and danazol causing rhabdomyolysis. Can J Clin Pharmacol 2003;10:172—4.
8. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002;41:343—370.
9. Wang JJ, Lee CL, Pan TM. Improvement of monacolin K, gama-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J Ind Microbiol Biotechnol 2003;30:669—76.
10. Vytorin (ezetimibe; simvastatin) package insert. North Wales, PA: MERCK/Schering-Plough Pharmaceuticals; 2014 Feb.
11. Simcor (niacin; simvastatin) package insert. North Chicago, IL: Abbott Laboratories; 2012 Oct.
12. Sandimmune® (cyclosporine) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2002 Mar.
13. Hansten P, Horn J. The Top 100 Drug Interactions: A Guide to Patient Management. includes table of CYP450 and drug transporter substrates and modifiers (appendices). H & H Publications, LLP 2014 edition.
14. Borras-Blasco J, Rosique-Robles JD, Peris-Marti J, et al. Possible cyclosporin-danazol interaction in a patient with aplastic anaemia. Am J Hematol 1999;62:63—4.
15. Tegretol® (carbamazepine) package insert. East Hanover, NJ. Novartis Pharmaceuticals; 2003 Sept.
16. Mignat C. Clinically significant drug interactions with new immunosuppressive agents. Drug Saf 1997;16:267—78.
17. Simons FER, Kesselman MS, Giddins NG et al. Astemizole-induced torsade de pointes. Lancet 1988 Sept 10; 2(8611):624.
18. Tikosyn™ (dofetilide) package insert. New York, NY: Pfizer Labs; 1999 Dec.
19. Migranal® (dihydroergotamine mesylate) nasal spray package insert. Aliso Viejo, CA: Valeant Pharmaceuticals; 2007 Jun.
20. D.H.E. 45® (dihydroergotamine mesylate) package insert. Stein, Switzerland: Novartis Pharmaceuticals AG; 2002 Sep.
21. Cafergot® (caffeine; ergotamine) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2002 June.
22. Bachmann K, He Y, Sarver JG, et al. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Xenobiotica 2003;33:265—76.
23. Halfan® (halofantrine) package insert. Philadelphia, PA: Smith Kline Beecham Pharmaceuticals; 2001 Oct.
24. Zemplar® (paricalcitol capsules) package insert. North Chicago, IL: Abbott Laboratories; 2005 May.
25. Quinidex Extentabs® (quinidine sulfate extended-release tablets) package insert. Richmond, VA: A.H. Robbins Company; 2000 Sept.
26. Aldercreutz H, Mazur W. Phyto-estrogens and western diseases. Annals of Medicine 1997;29:95—120.
27. Emend® capsules (aprepitant) package insert. Whitehouse Station, NJ: Merck & Co., Inc.; 2007 Nov.
28. Hectorol® (doxercalciferol) package insert. Middleton, WI: Bone Care International, Inc.; 2005 Jun.
29. Hansten PD, Horn JR. Top 100 Drug Interactions Monographs. In: The Top 100 Drug Interactions – A guide to Patient Management. 2007 Edition. Freeland, WA: H&H Publications; 2007:4—141.
30. Vesanoid® (tretinoin) capsules package insert. Nutley, NJ: Roche Laboratories Inc.; 2004 Oct.
31. Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol Rev 1992;11:41—57. Review.
32. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995;55:165—8. Review.
33. Rhinocort® Aqua™ (budesonide) nasal spray package insert. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2001.
34. Ranexa (ranolazine extended-release tablets) package insert. Foster City, CA: Gilead Sciences, Inc. 2013 Dec.
35. Sunitinib (Sutent®) package insert. New York, NY: Pfizer Labs; 2007 Feb.
36. Tracleer® (bosentan) package insert. South San Francisco, CA: Actelion Pharmaceuticals US, Inc.; 2007 Feb.
37. Letairis™ (ambrisentan) package insert. Foster City, CA: Gilead Sciences, Inc; 2008 Oct.
38. Tasigna® (nilotinib) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2007 Oct.
39. Spina E, Scordo MG, D’Arrigo C. Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol. 2003;17:517—38.
40. Seroquel® (quetiapine fumarate) package insert. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2006 Oct.
41. Ketek (telithromycin) package insert. Bridgewater, NJ: Sanofi-Aventis Pharmaceuticals; 2010 Dec.
42. Otani K, Aoshima T. Pharmacogenetics of classical and new antipsychotic drugs. Ther Drug Monit 2000;22:118-21.
43. Haldol injection for immediate release (haloperidol) package insert. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc.; 2011 Sept.
44. Imbruvica (ibrutinib) capsule package insert. Sunnyvale, CA:Pharmacyclics, Inc.;2015 Jan.
45. Humulin® (insulin) package insert. Indianapolis, IN: Eli Lilly and Company; 2000 Aug.
46. Burkhart KK, Metcalf S, Shurnas E, et al. Exchange transfusion and multidose activated charcoal following vancomycin overdose. Clin Toxicol 1992;30:285-294.
47. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity, and partial androgen deficiency. Aging Male 2003;6:1-7.
48. Hobbs CJ, Jones RE, Plymate SR. Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. J Clin Endocrinol Metab 1996; 81:1582-5.